Ikarian Capital, LLC Deciphera Pharmaceuticals, Inc. Call Options Transaction History

Ikarian Capital, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $1.52 Million - $2.48 Million	122,600 New	122,600 $2.27 Million
Q1 2022 May 13, 2022	SELL	$6.87 - $11.11 $204,726 - $331,078	-29,800 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $788,508 - $1.11 Million	29,800 New	29,800 $1.01 Million
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $5.65 Million - $7.94 Million	-140,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $6.13 Million - $8.14 Million	140,000 New	140,000 $7.18 Million
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $3.36 Million - $6.94 Million	-100,000 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$31.7 - $69.93 $3.17 Million - $6.99 Million	100,000 New	100,000 $6.22 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.